摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[(2R,4R,5R)-3-azido-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

中文名称
——
中文别名
——
英文名称
1-[(2R,4R,5R)-3-azido-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
英文别名
——
1-[(2R,4R,5R)-3-azido-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione化学式
CAS
——
化学式
C9H11N5O5
mdl
——
分子量
269.21
InChiKey
MRUKYOQQKHNMFI-PDVZPSIWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    114
  • 氢给体数:
    3
  • 氢受体数:
    7

文献信息

  • Biocatalytic synthesis of aminodeoxy purine N9-beta-D-nucleosides containing 3-amino-3-deoxy-beta-D-ribofuranose, 3-amino-2,3-dideoxy-beta-D-ribofuranose, and 2-amino-2-deoxy-beta-D-ribofuranose as sugar moieties
    申请人:Barai N. Vladimir
    公开号:US20070065922A1
    公开(公告)日:2007-03-22
    Purine N 9 -β-D-nucleosides containing 3-amino-3-deoxy-β-D-ribofaranose, 3-amino-2,3-dideoxy-β-D-ribofuranose, and 2-amino-2-deoxy-β-D-ribofuranose as sugar moieties are synthesized by biocatalytic transglycosylation of purine bases and the respective 3′-amino-3′-deoxyuridine, 3′-amino-3′-deoxythymidine and 2′-amino-2′-deoxyuridine as donors of the carbohydrate moiety, and the cells of Escherichia coli as a biocatalyst or glutaraldehyde (GA) treated cells of Escherichia coli as a biocatalyst or a mixture of thymidine (uridine) phosphorylase and purine nucleoside phosphorylase.
    含有3-氨基-3-脱氧-β-D-核糖呋喃糖,3-氨基-2,3-二脱氧-β-D-核糖呋喃糖和2-氨基-2-脱氧-β-D-核糖呋喃糖作为糖基团的嘌呤N9-β-D-核苷酸,通过生物催化转基因嘌呤碱基和相应的3'-氨基-3'-脱氧尿苷、3'-氨基-3'-脱氧胸苷和2'-氨基-2'-脱氧尿苷作为碳水化合物基团供体,以大肠杆菌细胞作为生物催化剂或经戊二醛处理的大肠杆菌细胞作为生物催化剂或胸苷(尿苷)磷酸化酶和嘌呤核苷酸磷酸化酶的混合物进行合成。
  • METHOD FOR IN VIVO TARGETING OF NANOPARTICLES VIA BIOORTHOGONAL COPPER-FREE CLICK CHEMISTRY
    申请人:KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    公开号:US20130251784A1
    公开(公告)日:2013-09-26
    The present disclosure relates to a method for in vivo targeting of a nanoparticle via bioorthogonal copper-free click chemistry, more particularly to a method for in vivo targeting of a nanoparticle, including: injecting a precursor capable of being metabolically engineered in vivo when injected into a living system and having a first bioorthogonal functional group into the living system; and injecting a nanoparticle having a second bioorthogonal functional group which can perform a bioorthogonal copper-free click reaction with the first bioorthogonal functional group attached thereto into the living system. In accordance with the present disclosure, accumulation of nanoparticles at a target site in a living system can be increased remarkably and the biodistribution of the nanoparticles can be controlled since the nanoparticles bound to a cell surface are taken up into the cell with time.
  • US9801943B2
    申请人:——
    公开号:US9801943B2
    公开(公告)日:2017-10-31
  • [EN] IMMOBILISED REAGENT<br/>[FR] REACTIF IMMOBILISE
    申请人:UNIV EDINBURGH
    公开号:WO2007110624A2
    公开(公告)日:2007-10-04
    [EN] There is describe an immobilised cyclic phosphitylation or immobilised cyclic phosphorylation reagent which includes a phosphinyl or phosphoryl moiety, in which respectively, the phosphorus (III) atom or phosphorus (V) atom is bonded within, and to, a ring system.
    [FR] L'invention concerne un réactif cyclique immobilisé de phosphitylation ou de phosphorylation, comprenant une fonction phosphinyle ou phosphoryle, l'atome de phosphore (III) ou l'atome de phosphore (V) étant respectivement lié à et dans un système cyclique.
查看更多